Skip to main content
OpenTrials

Clinical trial condition

Neurocognitive Disorders

Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.

7,804 public trials 1,438 recruiting studies
Refine in advanced search Browse all conditions

Neurocognitive Disorders trial results

Completed

A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

NCT04739423

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • The University of Sydney Sydney, New South Wales, Australia
  • Wesley Medical Research Ltd Brisbane, Queensland, Australia
  • Royal Melbourne Hospital Melbourne, Victoria, Australia
  • NZBRI Christchurch, New Zealand
View Trial Details
Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

NCT05108922

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • Neurology Center of North Orange County Fullerton, California, United States
  • Irvine Clinical Research Irvine, California, United States
  • California Neuroscience Research Medical Group, Inc. Sherman Oaks, California, United States
  • Institute for Neurodegenerative Disorders New Haven, Connecticut, United States
View all 31 locations
View Trial Details

Related conditions